|
Name |
beilunmycin
|
Molecular Formula | C28H37N3O6 | |
IUPAC Name* |
23-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14-trione
|
|
SMILES |
CC1=CCCC(O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)OC(C(C)C)C(C)C=CC(=O)NCC=C1
|
|
InChI |
InChI=1S/C28H37N3O6/c1-18(2)26-20(4)12-13-24(33)29-14-6-9-19(3)8-5-10-21(32)16-25-30-22(17-36-25)27(34)31-15-7-11-23(31)28(35)37-26/h6,8-9,11-13,17-18,20-21,26,32H,5,7,10,14-16H2,1-4H3,(H,29,33)/b9-6+,13-12+,19-8+/t20-,21+,26-/m1/s1
|
|
InChIKey |
ZQKMQEUDLIKXLZ-BGQOHLCHSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 511.62 | ALogp: | 3.5 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 122.0 | Aromatic Rings: | 3 |
Heavy Atoms: | 37 | QED Weighted: | 0.542 |
Caco-2 Permeability: | -4.969 | MDCK Permeability: | 0.00001590 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.293 |
Human Intestinal Absorption (HIA): | 0.556 | 20% Bioavailability (F20%): | 0.049 |
30% Bioavailability (F30%): | 0.283 |
Blood-Brain-Barrier Penetration (BBB): | 0.781 | Plasma Protein Binding (PPB): | 79.66% |
Volume Distribution (VD): | 1.806 | Fu: | 13.92% |
CYP1A2-inhibitor: | 0.023 | CYP1A2-substrate: | 0.066 |
CYP2C19-inhibitor: | 0.107 | CYP2C19-substrate: | 0.064 |
CYP2C9-inhibitor: | 0.316 | CYP2C9-substrate: | 0.151 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.505 |
CYP3A4-inhibitor: | 0.623 | CYP3A4-substrate: | 0.322 |
Clearance (CL): | 8.398 | Half-life (T1/2): | 0.889 |
hERG Blockers: | 0.02 | Human Hepatotoxicity (H-HT): | 0.33 |
Drug-inuced Liver Injury (DILI): | 0.165 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.137 | Maximum Recommended Daily Dose: | 0.947 |
Skin Sensitization: | 0.208 | Carcinogencity: | 0.899 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.782 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC005288 | 0.825 | D05AFC | 0.500 | ||||
ENC003558 | 0.778 | D05MNW | 0.329 | ||||
ENC002429 | 0.612 | D07XGH | 0.329 | ||||
ENC005087 | 0.276 | D00TLP | 0.222 | ||||
ENC003855 | 0.251 | D0L7LC | 0.218 | ||||
ENC001809 | 0.244 | D09NNH | 0.216 | ||||
ENC003463 | 0.244 | D06YFA | 0.207 | ||||
ENC002121 | 0.241 | D02IQY | 0.207 | ||||
ENC004297 | 0.240 | D06WTZ | 0.204 | ||||
ENC001855 | 0.240 | D03LJR | 0.202 |